Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Januar 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #799

    Bliver det lavere end nov, begynder det at stramme til.

    1 Reply Last reply
    0
    • K Offline
      K Offline
      KWC
      wrote on sidst redigeret af
      #800

      Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
      Company Announcement

      DARZALEX® (daratumumab) approved in Europe in combination with bortezomib, thalidomide and dexamethasone for the treatment of adult patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplant
      Approval follows positive opinion by European Committee for Medicinal Produ

      1 Reply Last reply
      0
      • K Offline
        K Offline
        KWC
        wrote on sidst redigeret af
        #801

        Copenhagen, Denmark; January 20, 2020 – Genmab A/S (Nasdaq: GMAB) announced today that the European Commission (EC) has granted marketing authorization for DARZALEX® (daratumumab) in combination with bortezomib, thalidomide and dexamethasone for the treatment of adult patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplant (ASCT). The EC approval follows a positive opinion issued for DARZALEX by the CHMP of the European Medicines Agency (EMA) in Decemb

        1 Reply Last reply
        0
        • K Offline
          K Offline
          KWC
          wrote on sidst redigeret af
          #802

          “With this approval, newly diagnosed patients with multiple myeloma who are eligible for ASCT may have the opportunity for treatment with a DARZALEX-containing regimen. We are extremely pleased that DARZALEX has received this latest approval and we look forward to the combination of DARZALEX plus bortezomib, thalidomide and dexamethasone being launched in Europe,” said Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab.

          The approval was based on the Phase III CASSIOPEIA (MMY3006) study

          1 Reply Last reply
          0
          • B Offline
            B Offline
            bikube
            wrote on sidst redigeret af
            #803

            Skidt med recepttallene denne gang, vi får det færdige resultat fra JnJ samme dag. Og dagens nyhed om godkendelse i EU må trække lidt op.

            1 Reply Last reply
            0
            • B Offline
              B Offline
              bikube
              wrote on sidst redigeret af
              #804

              Orv - Kan du huske det Pensionisten.

              1 Reply Last reply
              0
              • BulderB Offline
                BulderB Offline
                Bulder
                wrote on sidst redigeret af
                #805

                Det var hurtigt godkendelsen kom. Kun 5 uger og med jul og nytår ind imellem.

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #806

                  i was thinking the exact same. Nice.

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #807

                    And with Alcyone approved 1½ years ago we now have both transplant and non-transplant covered in the EU. Will probably add up sales numbers in 2020.

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #808

                      They submitted application March 27 last year. So all in all it took a little less than 10 mths.

                      1 Reply Last reply
                      0
                      • SolsenS Offline
                        SolsenS Offline
                        Solsen
                        wrote on sidst redigeret af
                        #809

                        https://www.bbc.com/news/health-51182451 Endnu en historie omkring en kur imod cancer. Lad da håbe at det denne gang er rigtigt.

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          peter12
                          wrote on sidst redigeret af
                          #810

                          Såvidt jeg kan se er det en gammel historie fra Basel (og ikke Cardiff). Nok lettere tænkt end gjort ? https://elifesciences.org/articles/24476

                          1 Reply Last reply
                          0
                          • StockBullS Offline
                            StockBullS Offline
                            StockBull
                            wrote on sidst redigeret af
                            #811

                            Morning 🙂 Trend intact https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/81007_trend_intact.JPG

                            1 Reply Last reply
                            0
                            • StockBullS Offline
                              StockBullS Offline
                              StockBull
                              wrote on sidst redigeret af
                              #812

                              1.5 års trend +forecast (godt til CFD handel)

                              1 Reply Last reply
                              0
                              • StockBullS Offline
                                StockBullS Offline
                                StockBull
                                wrote on sidst redigeret af
                                #813

                                Link Preview Image

                                1 Reply Last reply
                                0
                                • Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktør
                                  wrote on sidst redigeret af
                                  #814

                                  God morgen. 🙂

                                  1 Reply Last reply
                                  0
                                  • StockBullS Offline
                                    StockBullS Offline
                                    StockBull
                                    wrote on sidst redigeret af
                                    #815

                                    Den er er også meget sjov og man ser tydligt CWH er intakt https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/81009_sjov.JPG

                                    1 Reply Last reply
                                    0
                                    • J Offline
                                      J Offline
                                      Jørn_B
                                      wrote on sidst redigeret af
                                      #816

                                      @Stockbull. Tak... Lad os bare holde os til den sidste, så er jeg ikke utilfreds 🙂

                                      1 Reply Last reply
                                      0
                                      • BulderB Offline
                                        BulderB Offline
                                        Bulder
                                        wrote on sidst redigeret af
                                        #817

                                        Ritzau skriver at Cassiopeia er godkendt i Japan. Det passer vist ikke. Jeg har ikke kunnet finde noget på Japan. I USA derimod er Cass godkendt. Til gengæld kan vi snart forvente godkendelse af Maia i Japan. Ansøgning 5. april.

                                        1 Reply Last reply
                                        0
                                        • BulderB Offline
                                          BulderB Offline
                                          Bulder
                                          wrote on sidst redigeret af
                                          #818

                                          ... sidste år, og da Alcyone tog 9-10 mdr i Japan, må det være lige oppe over.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger